Walleye Trading
CTKB icon

Walleye Trading’s Cytek Biosciences CTKB Stock Holding History

Walleye Trading’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,863
Closed -$162K – 4916
2022
Q4 		$162K Buy
15,863
+5,168
+48% +$69.5K ﹤0.01% 3736
2022
Q3 		$157K Buy
+10,695
New +$139K ﹤0.01% 3848

Other funds holding CTKB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Walleye Trading's CTKB Position: Q1 2023 in Review

Walleye Trading sold out of Cytek Biosciences (CTKB) in Q1 2023, closing a stake of 15,863 shares — an estimated $162K sold.

Walleye Trading first reported a position in CTKB in Q3 2022 and held it in 2 quarters. The position peaked at $162K in Q4 2022. 102 funds tracked by Wall St. Rank hold CTKB as of Q1 2023.

  • Walleye Trading reported no remaining Cytek Biosciences position as of Q1 2023 after selling out during the quarter.
  • Walleye Trading sold 15,863 Cytek Biosciences shares in Q1 2023, an estimated $162K.
  • Walleye Trading first reported a position in Cytek Biosciences in Q3 2022 and held it in 2 quarters.
  • Walleye Trading's Cytek Biosciences position peaked at $162K in Q4 2022.
  • 102 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.